Tuesday, May 16 2023
08:40 AM – 09:00 AM PT
How to Vet if Your Idea is Worthy of Starting a Startup
Nicole K.. Paulk, PhD. University of California San Francisco, San Francisco, CA
Disclosures: N.K. Paulk: 1; Commercial Interest i.e. Company X; Dyno Therapeutics, GRO Biosciences, Astellas, Sarepta, Excision Biosciences, Alameda Biotherapeutics, CEVEC, WhiteLab Genomics. 1; What was received? i.e. Honorarium; Equity. 1; For what role? i.e. Speaker; Scientific Advisory Board. 2; Commercial Interest i.e. Company X; Bayer, Gordian Biotechnology, Arbor Biotechnologies, Iris Medicines. 2; What was received? i.e. Honorarium; Consulting fee. 2; For what role? i.e. Speaker; Consultant. 4; Commercial Interest i.e. Company X; Siren Biotechnology. 4; What was received? i.e. Honorarium; Salary, Equity. 4; For what role? i.e. Speaker; Employment.